Essential fatty acids and the brain.
OBJECTIVE
To review the role of essential fatty acids in brain membrane function and in the genesis of psychiatric disease.


METHODS
Medline databases were searched for published articles with links among the following key words: essential fatty acids, omega-3 fatty acids, docosahexanoic acid, eicosapentanoic acid, arachidonic acid, neurotransmission, phospholipase A2, depression, schizophrenia, mental performance, attention-deficit hyperactivity disorder, and Alzheimer's disease. Biochemistry textbooks were consulted on the role of fatty acids in membrane function, neurotransmission, and eicosanoid formation. The 3-dimensional structures of fatty acids were obtained from the Web site of the Biochemistry Department, University of Arizona (2001).


RESULTS
The fatty acid composition of neuronal cell membrane phospholipids reflects their intake in the diet. The degree of a fatty acid's desaturation determines its 3-dimensional structure and, thus, membrane fluidity and function. The ratio between omega-3 and omega-6 polyunsaturated fatty acids (PUFAs), in particular, influences various aspects of serotoninergic and catecholaminergic neurotransmission, as shown by studies in animal models. Phospholipase A2 (PLA2) hydrolyzes fatty acids from membrane phospholipids: liberated omega-6 PUFAs are metabolized to prostaglandins with a higher inflammatory potential, compared with those generated from the omega-3 family. Thus the activity of PLA2 coupled with membrane fatty acid composition may play a central role in the development of neuronal dysfunction. Intervention trials in human subjects show that omega-3 fatty acids have possible positive effects in the treatment of various psychiatric disorders, but more data are needed to make conclusive directives in this regard.


CONCLUSIONS
The ratio of membrane omega-3 to omega-6 PUFAs can be modulated by dietary intake. This ratio influences neurotransmission and prostaglandin formation, processes that are vital in the maintenance of normal brain function.
Department of Physiology, University of Pretoria, PO Box 2034, Pretoria 0001, South Africa. mhaag@medic.up.ac.za
Marianne
M
Haag
D000368:Aged; D000544:Alzheimer Disease / Q000378:metabolism*; D001289:Attention Deficit Disorder with Hyperactivity / Q000378:metabolism; D001921:Brain / Q000201:enzymology / Q000378:metabolism*; D002462:Cell Membrane / Q000378:metabolism; D015118:Eicosapentaenoic Acid; D005228:Fatty Acids, Essential / Q000378:metabolism*; D015525:Fatty Acids, Omega-3 / Q000378:metabolism; D043371:Fatty Acids, Omega-6; D005231:Fatty Acids, Unsaturated / Q000378:metabolism; D006801:Humans; D008043:Linseed Oil / Q000378:metabolism; D010740:Phospholipases / Q000378:metabolism; D011453:Prostaglandins / Q000096:biosynthesis; D013315:Stress, Psychological / Q000378:metabolism; D009435:Synaptic Transmission / Q000502:physiology
D005228:Fatty Acids, Essential; D015525:Fatty Acids, Omega-3; D043371:Fatty Acids, Omega-6; D005231:Fatty Acids, Unsaturated; D011453:Prostaglandins; D008043:Linseed Oil; D015118:Eicosapentaenoic Acid; D010740:Phospholipases